title: Exclusive bed for thrombolysis. A simple measure that allows 85% of ischemic stroke patients to be treated in the first hour.
abstract: The door-to-needle time is an important goal to reduce the time to treatment in intravenous thrombolysis. Objective Analyze if the inclusion of an exclusive thrombolytic bed reduces the door-to-needle time. Method One hundred and fifty patients admitted for neurological evaluation with ischemic stroke were separated in two groups: in the first, patients were admitted in the Emergency Room for intravenous thrombolysis (ER Group); in the second, patients were admitted in an exclusive thrombolytic bed in the general neurology ward (TB Group). Results Sixty-eight (86.0%) patients from TB Group were treated in the first 60 minutes of arrival as compared to 48 (67.6%) in the ER Group (p = 0.011). Conclusion The introduction of a thrombolytic bed in a general hospital setting can markedly reduce the door-to-needle time, allowing more than 85% of patients to be treated within the first hour of admission.
authors.affiliation: Departamento de Medicina Interna, Universidade Federal do Paraná, Curitiba, PR, Brazil.
authors.forename: Gabriella
authors.initials: G
authors.lastname: Tansini
authors.affiliation: Departamento de Medicina Interna, Universidade Federal do Paraná, Curitiba, PR, Brazil.
authors.forename: Renata Dal-Prá
authors.initials: RD
authors.lastname: Ducci
authors.affiliation: Departamento de Medicina Interna, Universidade Federal do Paraná, Curitiba, PR, Brazil.
authors.forename: Edison Matos
authors.initials: EM
authors.lastname: Nóvak
authors.affiliation: Departamento de Medicina Interna, Universidade Federal do Paraná, Curitiba, PR, Brazil.
authors.forename: Francisco Manoel Branco
authors.initials: FM
authors.lastname: Germiniani
authors.affiliation: Departamento de Medicina Interna, Universidade Federal do Paraná, Curitiba, PR, Brazil.
authors.forename: Viviane Flumignan
authors.initials: VF
authors.lastname: Zétola
authors.affiliation: Departamento de Medicina Interna, Universidade Federal do Paraná, Curitiba, PR, Brazil.
authors.forename: Marcos Christiano
authors.initials: MC
authors.lastname: Lange
mesh_terms: D001513:Beds; D061345:Early Medical Intervention; D004636:Emergency Service, Hospital / Q000458:organization & administration; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D018579:Patient Selection; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000295:instrumentation* / Q000379:methods; D061665:Time-to-Treatment / Q000458:organization & administration*
chemical_list: D005343:Fibrinolytic Agents